title: Influence of amesergide treatment on the dextromethorphan test.
authors.forename: P
authors.initials: P
authors.lastname: Baumann
authors.forename: M
authors.initials: M
authors.lastname: Hatzinger
authors.forename: U
authors.initials: U
authors.lastname: Hemmeter
authors.forename: E
authors.initials: E
authors.lastname: Seifritz
authors.forename: C B
authors.initials: CB
authors.lastname: Eap
authors.forename: E
authors.initials: E
authors.lastname: Holsboer
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D019389:Cytochrome P-450 CYP2D6; D065607:Cytochrome P-450 Enzyme Inhibitors; D003915:Dextromethorphan / Q000493:pharmacokinetics / Q000494:pharmacology*; D004873:Ergolines / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D010641:Phenotype; D012702:Serotonin Antagonists / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D000928:Antidepressive Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D004873:Ergolines; D012702:Serotonin Antagonists; D003915:Dextromethorphan; D006899:Mixed Function Oxygenases; D019389:Cytochrome P-450 CYP2D6; C066736:amesergide